Neolys Pharma

📍 Quebec City, Canada🗓 Founded 2023👥 7 employees💰 Last funded Nov 2023
Biotechnology Research🌐 neolyspharma.com
Website LinkedIn
RM-581, a small molecule in early developpement of a new class (the aminosteroids), demonstrated its ability to block the progression or even reduce the size of cancerous tumours that are difficult to treat with conventional chemothérapy. Le RM-581, une petite molécule en développement préclinique dune nouvelle classe (les aminostéroïdes), a démontré une capacité à bloquer la progression ou même réduire réduire la taille des tumeurs cancéreuses difficiles à traiter avec la chimiothérapie classique.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Canada
1
Frequently asked questions
Who invested in Neolys Pharma?
Neolys Pharma has 1 investors on record on gritt.io.
When did Neolys Pharma last raise funding?
The most recent investment in Neolys Pharma recorded on gritt.io was in November 2023.
When was Neolys Pharma founded?
Neolys Pharma was founded in 2023.
What industry is Neolys Pharma in?
Neolys Pharma operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Neolys Pharma based?
Neolys Pharma is headquartered in Quebec City, Canada.